The Johns Hopkins University School of Medicine and the Johns Hopkins Bloomberg School of Public Health will receive more than $2 million per year in a five-year grant from the National Institutes of Health’s National Cancer Institute to form a center for studying the immune response to SARS-CoV-2, the virus that causes COVID-19.
The goal of the Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-EPICS) is to provide a deeper understanding of how the virus impacts the immune system in order to facilitate development of effective treatments and vaccines against it.